1. Home
  2. MDWD vs FCCO Comparison

MDWD vs FCCO Comparison

Compare MDWD & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • FCCO
  • Stock Information
  • Founded
  • MDWD 2000
  • FCCO 1994
  • Country
  • MDWD Israel
  • FCCO United States
  • Employees
  • MDWD N/A
  • FCCO N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • FCCO Major Banks
  • Sector
  • MDWD Health Care
  • FCCO Finance
  • Exchange
  • MDWD Nasdaq
  • FCCO Nasdaq
  • Market Cap
  • MDWD 208.2M
  • FCCO 182.4M
  • IPO Year
  • MDWD 2014
  • FCCO 1998
  • Fundamental
  • Price
  • MDWD $20.72
  • FCCO $24.98
  • Analyst Decision
  • MDWD Strong Buy
  • FCCO Strong Buy
  • Analyst Count
  • MDWD 2
  • FCCO 2
  • Target Price
  • MDWD $35.00
  • FCCO $30.00
  • AVG Volume (30 Days)
  • MDWD 49.2K
  • FCCO 75.7K
  • Earning Date
  • MDWD 08-13-2025
  • FCCO 07-23-2025
  • Dividend Yield
  • MDWD N/A
  • FCCO 2.37%
  • EPS Growth
  • MDWD N/A
  • FCCO 37.48
  • EPS
  • MDWD N/A
  • FCCO 1.98
  • Revenue
  • MDWD $19,213,000.00
  • FCCO $67,933,000.00
  • Revenue This Year
  • MDWD $20.80
  • FCCO $18.61
  • Revenue Next Year
  • MDWD $26.92
  • FCCO $11.88
  • P/E Ratio
  • MDWD N/A
  • FCCO $12.79
  • Revenue Growth
  • MDWD N/A
  • FCCO 16.46
  • 52 Week Low
  • MDWD $14.14
  • FCCO $16.40
  • 52 Week High
  • MDWD $22.51
  • FCCO $27.96
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 64.88
  • FCCO 65.01
  • Support Level
  • MDWD $19.07
  • FCCO $25.01
  • Resistance Level
  • MDWD $19.55
  • FCCO $25.95
  • Average True Range (ATR)
  • MDWD 0.65
  • FCCO 0.49
  • MACD
  • MDWD 0.12
  • FCCO 0.18
  • Stochastic Oscillator
  • MDWD 94.01
  • FCCO 79.89

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

Share on Social Networks: